-
IntroducedJan 05, 2024
-
Passed Senate
-
Passed House
-
Signed into Law
International Drug Reference Pricing; Providing legislative policy; requiring prescription drug manufacturer permitholders to annually report certain international price data to the Agency for Health Care Administration; providing for administrative enforcement by a specified fine and permit suspension; requiring the agency to contract with an entity to designate reference price source countries and establish the reference prices for prescription drugs based on certain criteria; requiring the agency contractor to reevaluate the designated reference prices source countries annually and revise, as needed, etc.
Last Action See all actions
Senate • Mar 08, 2024: Died in Health Policy
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on SB 1750
Tweets
Whip Lists
Sponsors
Votes
Actions
- Mar 08, 2024 | Senate
- Died in Health Policy
- Jan 11, 2024 | Senate
- Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
- Introduced
- Jan 05, 2024 | Senate
- Filed
Bill Texts
Documents